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Abstract
This study reviewed the clinical, laboratory, therapeutic and prognostic data on genitourinary involvement of brucellosis in this largest case
series reported. This multicentre study pooled adult patients with genitourinary brucellar involvement from 34 centres treated between
2000 and 2013. Diagnosis of the disease was established by conventional methods. Overall 390 patients with genitourinary brucellosis (352
male, 90.2%) were pooled. In male patients, the most frequent involved site was the scrotal area (n = 327, 83.8%), as epididymo-orchitis
(n = 204, 58%), orchitis (n = 112, 31.8%) and epididymitis (n = 11, 3.1%). In female patients, pyelonephritis (n = 33/38, 86.8%) was
signiﬁcantly higher than in male patients (n = 11/352, 3.1%; p< 0.0001). The mean blood leukocyte count was 7530  3115/mm3. Routine
laboratory analysis revealed mild to moderate increases for erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). The mean
treatment duration and length of hospital stay were signiﬁcantly higher when there were additional brucellar foci (p< 0.05). Surgical
operations including orchiectomy and abscess drainage were performed in nine (2.3%) patients. Therapeutic failure was detected in six
(1.5%), relapse occurred in four (1%), and persistent infertility related to brucellosis occurred in one patient. A localized scrotal infection in
men or pyelonephritis in women in the absence of leucocytosis and with mild to moderate increases in inﬂammatory markers should signal
the possibility of brucellar genitourinary disease.
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Introduction
Brucellosis is a major zoonotic disease in many parts of the
world, especially in South and Central America, India, the
Mediterranean and the Middle East [1]. The disease is an
endemic zoonosis in Turkey, too. The reported incidence of
brucellosis in Turkey by theTurkishMinistry ofHealthwas 256.7
cases per million in 2004 [2]. Human brucellosis occurs as a
systemic infectious disease with various clinical manifestations.
The generalized symptoms, consisting of fever, night sweats and
malaise, are not disease speciﬁc and can mimic many diseases,
particularly tuberculosis, typhoid fever, infectious mononucle-
osis, Hodgkin’s disease, HIV infection and malaria. Brucellae
spread to tissues, rich in elements of reticulo-endothelial system
by the haematogenous route and localizes mainly at the joints,
central nervous system (CNS), cardiovascular system (CVS),
respiratory system and genitourinary tract [3–8].
Brucellae can affect the genitourinary tract in different ways in
male patients, while data are relatively lacking for female
patients. Approximately 10% of brucellosis cases have genito-
urinary complications, with epididymo-orchitis being the most
frequent [9]. However, reports from Turkey suggest a lower
incidence (1–4.3%) [5–8]. Brucella epididymo-orchitis patients
may present at urology clinics with testicular lesions resembling
tumours or tuberculosis [10,11], renal [12] and testicular [13]
abscesses, and prostatitis [14]. Few reports have focused on
genitourinary brucellosis, with most being small case series
[15–19]. This multicentre retrospective study provides the
largest series reported, detailing clinical, laboratory, therapeu-
tic and prognostic features of genitourinary brucellosis.
Methods
Study design and patient population
Only adult patients over the age of 15 years with genitourinary
brucellosis were enrolled in this study. This retrospective
multicentre study pooled patients from 34 medical centres in
Turkey. The diagnosis of genitourinary brucellosis was made
by the clinicians at the participating centres. No control group
was included in the study. Fatih Sultan Mehmet Training and
Research Hospital’s Review Board in Istanbul approved the
study.
Microbiological, serological, routine laboratory and
radiological investigations
Blood, bone marrow, abscess and body ﬂuid cultures were
taken for diagnostic purposes. Blood and bone marrow
specimens were cultivated using automated systems, mainly
BACTECTM 9240 (Becton-Dickinson, Sparks, MD, USA) and
the PhoenixTM Diagnostic System (Becton–Dickinson Diagnos-
tic Instrument System). Blood samples were cultivated for
14 days. Clinical specimens other than blood and bone
marrow were inoculated onto sheep blood agar and chocolate
agar. All isolates were deﬁned by standard microbiological
techniques such as motility, oxidase, catalase, glucose fermen-
tation, production of H2S and urease. Brucella abortus S99
antigen obtained from the Pendik Animal Diseases Research
Institute (Istanbul, Turkey) was used for serum tube aggluti-
nation test (SAT). The Rose Bengal test (Pendik Animal
Diseases Research Institute) and Coombs’ agglutination (Coo-
mbs-SAT) test were used for serological analysis. Routine
laboratory analyses for all patients, ultrasonography (USG) and
other diagnostic imaging studies were performed according to
the symptoms of the patients.
Deﬁnitions
Diagnosis of brucellosis. The diagnosis was based on clinical
ﬁndings for brucellosis, including fever, night sweats, arthralgia,
hepatomegaly and splenomegaly, positive SAT (titre ≥1:160) or
Rose Bengal test, and/or isolation of Brucellae from blood,
other tissues, urine cultures or ﬂuids [20].
Classiﬁcation of brucellosis. Patients were subclassiﬁed into
acute, subacute and chronic stages according to the duration
of the disease, as less than 8 weeks, from 8 to 52 weeks and
more than 1 year, respectively [21].
Epididymo-orchitis. A brucellosis patient with epididymal and
testicular tenderness, and/or ﬂorid inﬂammation of the scrotum,
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and enlargement and/or oedema on physical examination and/or
on USG was classiﬁed as epididymo-orchitis [16].
Pyelonephritis. A brucellosis patient with upper urinary tract
infection including fever, ﬂank pain and costovertebral angle
tenderness and/or isolation of Brucellae from the urine cultures
or renal oedema and inﬂammation detected by USG was
categorized as pyelonephritis.
Prostatitis. A brucellosis patient with symptoms and signs of
prostatitis with oedema and inﬂammation of the prostate on
USG or typical histological appearance in a prostate biopsy
specimen was conﬁrmed as prostatitis.
Acute kidney injury. An abrupt (within 48 h) and absolute
increase in the serum creatinine concentration of ≥0.3 mg/dL
from baseline, a percentage increase in the serum creatinine
concentration of ≥50%, or oliguria of <0.5 mL/kg per hour for
more than 6 h, was classiﬁed in as acute kidney injury [22].
Patients with kidney damage and evidence of obstruction,
diabetes mellitus, systemic lupus erythematosus, chronic renal
failure or underlying renal diseases were excluded.
Glomerulonephritis. A patient with typical histological appearance
compatible with glomerulonephritis on microscopic examination
of a kidney biopsy specimen was recorded in this category.
Genitourinary involvement. This group comprised brucellosis
patients with genitourinary or urinary involvement.
Therapeutic failure. The persistence or deterioration of symp-
toms and signs related to brucellosis and/or brucellar genito-
urinary involvement at the end of therapy was considered as a
therapeutic failure [8].
Relapse. This was deﬁned as reappearance of clinical signs and
symptoms of brucellosis during the 12 months after the
treatment [21].
Treatment
All patients were treated with various combinations of
antibiotics after the diagnosis, such as doxycycline, rifampicin,
ciproﬂoxacin, trimethoprim/sulfamethoxazole orally, and an
aminoglycoside (streptomycin and gentamicin) and ceftriaxone
parenterally, with the appropriate doses and durations at the
participant centres. All patients were followed-up and exam-
ined daily by the same physicians during the hospitalization
period. Patients were followed-up for at least 6 weeks after
completion of therapy; cure, therapeutic failure, relapse and
death (if it occurred) were recorded for each patient.
Data collection and statistical methods
A standard questionnaire was sent to the participant centres
via the internet and data were collected by using a computer
database. Demographic and epidemiological data, clinical and
laboratory data including symptoms and signs, co-existent foci
of brucellosis, underlying diseases, routine and other diagnos-
tic laboratory test results, imaging ﬁndings and the results of
organ biopsies, treatment and outcome data such as drug
combinations used, duration of treatments, therapeutic fail-
ures, cure, relapse, surgical operations and length of stay (LOS)
in the hospitals were retrieved from the patient charts and
recorded for each patient by the local physicians at the
participating centres. Patients were divided into two groups
for comparative analysis; group one did not have focal infection
and group two comprised those with additional involved sites.
The data analysis was performed with SPSS in the Windows
V.16.0 program. Descriptive statistics were presented as
frequencies, percentages for categorical variables and
mean  standard deviation (range) for continuous variables.
Numerical data were ﬁrst tested for normality and then
analysed using Student’s t-test for parametric data; the Mann–
Whitney U-test was used for variables for non-parametric data
for group comparisons. Categorical data were analysed using
the chi-square and Fisher’s exact tests. All tests were
two-tailed and statistical signiﬁcance was assigned to p values
less than 0.05.
Results
Patient characteristics
Overall 390 patients with genitourinary brucellosis (352 male
patients, 90.2%) were studied. The mean age of the patients
was 39.66  14.94 (range, 15–85) years. The clinical signs and
symptoms of the patients were presented in Table 1. Fatigue
(86.9%), night sweats (83.6%) and fever (82.3%) were the most
frequent symptoms and fever (44.9%), hepatomegaly (23.8%)
and splenomegaly (19%) were the most frequent signs found in
the patients on admission. In addition to the major symptoms
of brucellosis, the following genitourinary symptoms were
observed in female patients: dysuria in 21 (55.3%) out of 38
patients, haematuria in 10 (26.3%) and genital discharge in four
(10.5%). Testicular complaints included tenderness, swelling
and hyperaemia in 345 (98%), dysuria in 71 (20.2%), urethral
discharge in 20 (5.7%) and haematuria in 16 (4.5%) out of 352
males with genitourinary complaints.
The mean duration between the onset of symptoms and
hospital admission was 15.9  19.9 (range, 1–210) days. In
other words, 375 (96.2%) patients presented to hospital within
2 months of the onset of symptoms. Previous history of
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brucellosis was recorded in 29 (7.4%) cases, with a mean of
16.7  14.3 months. Eighteen out of these 29 patients (62%)
had suitable treatment for their previous episode of
brucellosis.
The concomitant diseases were as follows: diabetes mellitus
in 17 (4.4%), urinary stones in 11 (2.8%), benign prostate
hypertrophy in 10 (2.6%), hypertension in 8 (2.1%), acute
kidney injury related to brucellosis in 7 (1.7%), chronic
hepatitis in 3 (0.8%) and other disease in nine patients (2.3%)
(cerebrovascular event, 1; drug addiction, 1; orchiectomy
operation, 1; rheumatic disease, 1; coronary artery disease,
1; lumbar disc hernia, 1; facial paralysis, 1; cardiac failure,
1; chronic bronchitis, 1). Patients were neither immunosup-
pressed nor using immunosuppressive drugs.
Microbiological, serological, routine laboratory and
radiological investigations
Serological results were as follows: Rose Bengal test, 91.6%
(328/358); SAT, 94% (363/386); Coombs-SAT, 92.9% (91/98).
Blood cultures were positive in 36.5% (91/249), bone marrow
culture in 63.6% (7/11), urine culture in 1.5% (3/201) and
genital discharge culture in 5.9% (2/34). Overall, 56 (54.4%) out
of 103 isolates were typed as Brucella melitensis, and the
remainder reported as Brucella spp. The results of routine
laboratory analyses and USG ﬁndings in patients with genito-
urinary system brucellosis are presented in Tables 2 and 3,
respectively.
Genitourinary and other foci of infection
The most frequent involved site was the scrotal area (n = 327,
83.8% of all patients and 93% of male patients), as epididy-
mo-orchitis (n = 204, 58%), orchitis (n = 112, 31.8%) and
epididymitis (n = 11, 3.1%), (Table 4). Clinical, laboratory and
radiological evaluations revealed additional brucellar focus or
foci in 110 patients (28.2%). The distribution of additional
organ involvements were as follows: sacroiliitis, 52 (13.3%);
spondylodiscitis, 34 (8.7%); clinical hepatitis, 14 (3.6%) (>5
times upper limit of normal for aminotransferases); peripheral
arthritis, 21 (5.4%); meningoencephalitis, 6 (1.5%); others, 9
(2.3%). On the other hand, pyelonephritis in female patients
(33/38, 86.8%) was signiﬁcantly higher than in male patients
(11/352, 3.1%) (p< 0.0001; OR (95% CI), 204.6 (67–624.7)).
Treatment
Antibiotic combinations were as follows: doxycycline and
rifampicin (n = 229, 63.6%); doxycycline, rifampicin and an
aminoglycoside (n = 46, 12.8%); doxycycline and an
aminoglycoside (n = 44, 12.2%); doxycycline, rifampicin and
TABLE 1. Clinical symptoms and signs in genitourinary
system brucellosis (n = 390)
Symptoms n (%)
Fatigue 339 (86.9)
Night sweats 326 (83.6)
Fever 321 (82.3)
Loss of appetite 227 (58.2)
Arthralgia 215 (55.1)
Weight loss 212 (54.4)
Lower back pain 200 (51.3)
Dysuria 93 (23.8)
Testicular complaints in men (n = 352) 345 (98.0)
Signs
Fever (≥38°C) 175 (44.9)
Hepatomegaly 93 (23.8)
Splenomegaly 74 (19.0)
Haematuria 26 (6.7)
Genital discharge 24 (6.2)
Costovertebral angle tenderness 13 (3.3)
Scrotal signs in men (n = 352)
Tendernessa 325 (92.3)
Swellingb 317 (90.1)
Hyperaemiac 284 (80.7)
aRight testicle, 128; left testicle, 114; bilateral, 83.
bRight testicle, 129; left testicle, 131; bilateral, 57.
cRight testicle, 117; left testicle, 107; bilateral, 60.
TABLE 2. Laboratory ﬁndings of brucellosis cases with
genitourinary system involvement on admission (n = 390)
Mean  SD Normal
Leucocyte count (x103/L) 7530  3115 4000–11 000
Haemoglobin (g/dL) 12.7  1.9 14–18 for men
12–16 for women
Platelet (x103/L) 235 400  91 606 150 000–450 000
Erythrocyte sedimentation
rate (mm/hr)
35.3  20.7 ≤15 for men
≤20 for women
C-reactive protein (mg/L) 28.2  39.9 0–8
Alanine aminotransferase (IU/L) 53.6  89.5 17–63
Aspartate aminotransferase (IU/L) 51.2  77.2 15–41
Alkaline phosphatase
(IU/L) (n = 271)
147  115 41–133
Creatine phosphokinase
(U/L) (n = 172)
168  256 60–400
Lactate dehydrogenase
(U/L) (n = 236)
332  407 140–280
Blood urea nitrogen
(mg/dL) (n = 360)
28.7  16.6 7–20
Creatinine (mg/dL) (n = 360) 0.80  0.74 0.7–1.2
TABLE 3. The results of ultrasonographic evaluation of
patients with genitourinary system brucellosis
Abdominal ﬁndings (n = 271) Number Per cent
Hepatomegaly 82 30.3
Splenomegaly 72 26.6
Peritoneal ﬂuid 11 4.1
Renal involvement (damage) 5 1.8
Abscess 3a 1.1
Others 2b 0.7
Scrotal/genitourinary ﬁndings (n = 348)
Inﬂammation 315 90.5
Oedema 286 82.2
Testicular involvement 279c 80.2
Genital mass 25 7.2
Genital abscess 21 6.0
Others 28d 8.0
aTubo-ovarian, 1; abdominal, 1; splenic, 1.
bAbdominal lymphadenopathy, 1; pyonephrosis, 1.
cRight testicle, 151 (54.1%); left testicle, 90 (33.3%); bilateral, 38 (13.6%).
dEpididymitis, 17; prostatitis, 3; varicocele, 4; tubo-ovarian abscess, 1; localized
ﬂuid, 3.
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trimethoprim/sulfamethoxazole (n = 13, 3.6%); ceftriaxone,
doxycycline and rifampicin (n = 17, 4.7%); doxycycline, rifam-
picin and ciproﬂoxacin (n = 16, 4.4%); and others (n = 25,
6.9%). Surgery was performed in nine patients (2.3%) and
orchiectomy was performed in six (1.5%) patients. Abscess
drainage was performed in two cases (one was in the
paravertebral area) and lumbar stabilization was established
in one case.
Outcome analysis
Therapeutic failure was recorded in six (1.5%) patients. Failure
was recorded when there was worsening of the clinical picture
(n = 4), persistence of raised ESR and CRP (n = 1), abscess
formation (n = 2) or worsening of USG ﬁndings (n = 1). All of
these patients except one responded well to antibiotic
modiﬁcations. A drainage operation was needed in a male
patient due to development of a testicular abscess during
follow-up. Four (1%) cases relapsed after the end of antibiotic
treatment, and infertility related to brucellosis persisted in one
patient. Symptoms of genitourinary brucellosis reappeared in
two out of four relapsed cases. Patients with solitary
genitourinary involvement (n = 279) had a LOS in hospital of
9.6  5.6 (1–30) days for the doxycycline and rifampicin
combination, whilst it was 14.1  6.0 (2–30) days for the
doxycycline, rifampicin and streptomycin regimen (p 0.001).
Six out of 38 (15.8%) female patients were pregnant
(6–32 weeks of gestation). Gestation ended with spontaneous
abortion in two, preterm labour in one and term birth in three.
No death was observed for this cohort.
Comparison of treatment and outcome data for genitouri-
nary system brucellosis patients without other coexistent focal
disease and with other involved sites is presented in Table 5.
Both the mean treatment duration and LOS in hospital was
signiﬁcantly higher in the presence of additional foci of
infection (63 vs. 47.2 days, p< 0.0001 and 13.2 vs. 10 days,
p 0.001, respectively).
Discussion
Epidiymo-orchitis as a consequence of brucellosis was
observed in one-tenth of patients [9]. Genitourinary involve-
ment in human brucellosis raises the possibility of sexual
dissemination [23]. Misdiagnosis leading to irrational therapies
in this syndrome may result in serious genitourinary compli-
cations, including abscess formation [24], infarction [25],
atrophy [26], suppurative necrosis [27], failure of spermato-
genic function, infertility and testicular loss in a signiﬁcant
portion of cases [28]. In this study, 90% of the patients were
male and 93% of them experienced epididymitis and/or
orchitis. Female patients were more likely to have pyelone-
phritis compared with male patients (86.8% vs. 3.1%). How-
ever, when the brucellosis cases with pyelonephritis were
taken as a whole, one-fourth of the cases were in male
patients. Thus, pyelonephritis related to brucellosis is not
necessarily a female disease. Added to that, glomerulonephritis
was also seen infrequently in both sexes. This datum appeared
to be one of the most interesting ﬁndings of this study because
pyelonephritis has been rarely reported in the past. In fact,
nephritis was believed to be a frequent complication of
endocarditis in brucellosis patients [29]. However, none of
our patients had coexistent endocarditis. Fallopian tube and
tubo-ovarian abscesses were seen in 8% of the women
affected while prostatitis (1.4%) and testicular/scrotal (1.7%)
abscess formation were occasionally recorded in male
patients.
Constitutional symptoms related to brucellosis, such as
night sweats, fatigue and fever, were seen in more than
four-ﬁfths of the cases. The most frequent symptoms for male
patients with brucellosis were testicular complaints in 98% of
TABLE 4. Final clinical diagnosis of genitourinary system
brucellosis cases according to gender
Diagnosis Number Per cent
Male patients (n = 352)
Orchitis 112a 31.8
Epididymitis 11b 3.1
Epididymo-orchitis 204c 58
Pyelonephritis 11 3.1
Abscess formation 6d 1.7
Prostatitis 5 1.4
Glomerulonephritis 1 0.3
Female patients (n = 38)
Pyelonephritis 33 86.8
Glomerulonephritis 2 5.3
Fallopian tube abscess 2 5.3
Tubo-ovarian abscess 1 2.6
aTesticular abscess (additional diagnosis), 1.
bUrethritis (additional diagnosis), 1.
cTesticular abscess (additional diagnosis); 1, prostatitis (additional diagnosis), 1.
dTesticular abscess, 5; scrotal abscess, 1.
TABLE 5. Comparison of genitourinary system brucellosis
patients without other coexistent focal disease (group 1) and
those with another involved site (group 2)
Group 1 (n = 279) Group 2 (n = 111) p-Value
Mean treatment
duration 
SD, days (range)
47.2  11.7 (42–90) 63.0  38.9 (42–240) <0.0001
Mean LOS  SD,
days (range)
10.0  5.7 (1–30) 13.2  8.5 (1–60) 0.001
Failure, n (%) 4 (1.4) 2 (1.8) 1.0
Relapse, n (%) 3 (1.1) 2 (1.8) 0.626
Surgical intervention
(needed), n (%)
6 (2.2) a 2 (1.8)b 1.0
LOS, length of hospital stay.
aAll genital surgery.
bSpinal surgery, 1; orchiectomy, 1.
ª2014 The Authors
Clinical Microbiology and Infection ª2014 European Society of Clinical Microbiology and Infectious Diseases, CMI, 20, O847–O853
CMI Erdem et al. Genitourinary Brucellosis O851
the cases. Accordingly, the physical examination revealed
tenderness, swelling and hyperaemia in more than 80% of
these male patients. Other speciﬁc ﬁndings related to genito-
urinary system, such as dysuria, haematuria, genital discharge
and costovertebral tenderness, were seen in less than
one-fourth of all patients in descending order. Thus, the
results of this study show that the testes are the primary
targets for male patients with brucellosis. Interestingly, when
laboratory data were evaluated, the inﬂammatory markers did
not raise much suspicion of an infection. For example, the
mean value of white blood cells was within the normal range in
this study. There were initial reports from relatively small case
series in accordance with this datum [19] and it may help
differentiate brucellar disease with genitourinary involvement
from other pyogenic infections. Accordingly, we observed mild
to moderate increases for erythrocyte sedimentation rate,
C-reactive protein, lactate dehydrogenase, liver enzymes and
alkaline phosphatase values in our study. Moreover, abdominal
ﬁndings detected by USG were not decisive. Interestingly, in
4% of the cases a minimal amount of free intraperitoneal ﬂuid,
which disappeared with treatment, was detected. This was
probably due to lymphatic involvement obstructing the
drainage. The most frequent ﬁndings were liver and spleen
enlargements, observed in less than one-third of the patients.
Accordingly, the clinicians recorded hepatomegaly and spleno-
megaly with manual examination in one-ﬁfth of the cases. In
contrast, ﬁndings of scrotal USG were associated with
epididymitis and/or orchitis in more than 80% of male patients.
Unilateral testicular involvement was seen in most of the cases
while both testes were involved in 13.6%.
Human brucellosis poses a therapeutic dilemma owing to
the intracellular localization of the bacterium within the host’s
reticuloendothelial cells, a site relatively inaccessible to
antibiotics. Therefore, the proper combination of antibiotics
for an adequate duration is warranted to improve outcome
and prevent relapses [30]. In this study, 1.5% of the patients
failed to respond to therapy and required antibiotic modiﬁca-
tion. Subsequently, the infection was eradicated with modiﬁed
antibiotic combinations. Accordingly, 7.4% of our cases were
relapses of previous brucellosis with an additional 1% of our
study patients showing relapse after antibiotic treatment. Half
of these clinical relapses experienced genitourinary brucellosis,
but responded well to further antibiotic regimens. One of the
male patients was reported to experience secondary infertility
as a sequela.
In this study, 136 other focal involvements were detected in
110 (28.2%) out of 390 patients with genitourinary brucellosis,
most frequently within the skeletal system. In these patients
the mean duration of treatment was almost 2 weeks higher. In
addition, LOS was signiﬁcantly longer in patients with
additional brucellar foci. Thus, the treatment of genitourinary
brucellosis seems to be hampered by the presence of other
focal complications. Although various antibiotic combinations
were used in this study, doxycycline and rifampicin was the
most common regimen used, and adding streptomycin to this
regimen extended LOS from 10 days to 2 weeks on average.
This is likely to reﬂect the reluctance of clinicians to discharge
patients until completion of parenteral streptomycin treat-
ment. Therapeutic regimens used in this study generally
provided satisfactory results. Additional surgery was per-
formed in nine (2.3%) cases. Orchiectomy, the most frequent
procedure, was followed by abscess drainage and lumbar
stabilization in a patient with coexistent spondylodiscitis. Early
diagnosis with prompt initiation of antibiotics in these patients
may decrease the need for surgery as in other forms of
brucellosis [31].
Genitourinary brucellosis in female patients is known to be
associated with intrauterine infection, foetal death, premature
delivery, abortion and low birth weight, particularly within the
ﬁrst and second trimesters [32–34]. In addition, surviving
newborns may experience serious sequelae [35,36]. One-sixth
of female patients in this study were pregnant and all with
gestational ages less than 32 weeks. Half of them experienced
a problematic course, two ended with spontaneous abortion
and one with preterm labour. Thus, although data seem to be
relatively lacking on this issue, early diagnosis and initiation of
antibiotics is likely to be of paramount importance for the
foetus and newborn in this subgroup of patients [37].
Diagnosis of genitourinary brucellosis requires a detailed
history, a meticulous physical examination and a detailed
laboratory and radiological evaluation. According to data
collated from this largest known case series to date, localized
infection related to the testicular area and its surroundings in
men or pyelonephritis in women in the absence of leucocytosis
and with mild to moderate increases for inﬂammatory markers
should alert clinicians to potential genitourinary brucellosis.
Coexistent arthritis or arthralgia and accompanying mild to
moderate increases in liver function tests and ALP in a patient
with probable genitourinary infection may strengthen the
suspicion of brucellosis even in non-endemic areas. The
diagnosis supported by microbiological and serological tests
should be used to differentiate patients with genitourinary
infection.
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